We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Wants Teva, Ivax to Sell Off Drug Rights Before Merger
FTC Wants Teva, Ivax to Sell Off Drug Rights Before Merger
January 24, 2006
The FTC has cleared a pending merger between Teva and Ivax, but said the two companies must sell off manufacturing and/or marketing rights to 15 generic drugs, according to a Jan. 23 consent order.